CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 33 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $12,000 | -33.3% | 50,000 | 0.0% | 0.00% | – |
| Q4 2017 | $18,000 | -30.8% | 50,000 | 0.0% | 0.00% | – |
| Q3 2017 | $26,000 | -43.5% | 50,000 | -37.5% | 0.00% | – |
| Q2 2017 | $46,000 | -67.6% | 80,000 | 0.0% | 0.00% | – |
| Q1 2017 | $142,000 | -10.1% | 80,000 | 0.0% | 0.00% | – |
| Q4 2016 | $158,000 | +393.8% | 80,000 | +166.7% | 0.00% | – |
| Q3 2016 | $32,000 | +3.2% | 30,000 | 0.0% | 0.00% | – |
| Q2 2016 | $31,000 | -13.9% | 30,000 | 0.0% | 0.00% | – |
| Q1 2016 | $36,000 | +140.0% | 30,000 | +200.0% | 0.00% | – |
| Q4 2015 | $15,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospera Financial Services Inc | 90,800 | $140,000 | 0.03% |
| Spark Investment Management LLC | 90,800 | $139,000 | 0.02% |
| Cambridge Investment Research Advisors, Inc. | 27,219 | $42,000 | 0.00% |
| Vantage Investment Advisors, LLC | 1,150 | $2,000 | 0.00% |
| Balentine LLC | 55 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 177 | $0 | 0.00% |
| UBS Group AG | 6,211 | $10,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 5,453 | $8,000 | 0.00% |
| Wealthspire Advisors, L.P. | 207 | $0 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 283 | $0 | 0.00% |